XIST and central nervous system cancer: XIST expression was significantly up-regulated in glioma tissues and cell lines, compared with PTBE tissues and NHA cell line, respectively; further, a higher XIST expression was correlated with a poorer prognosis in patients with glioma, including larger tumor size, advanced WHO stages, and shorter OS.